نتائج البحث

Contribution of the PD-1 ligands/PD-1 signaling pathway to dendritic cell-mediated CD4+ T cell activation

• Authors : Kuipers, H.; Muskens, F.; Willart, M.

• Source: Kuipers , H , Muskens , F , Willart , M , Hijdra , D , van Assema , F B , Coyle , A J , Hoogsteden , H C & Lambrecht , B N 2006 , ' Contribution of the PD-1 ligands/PD-1 signaling pathway to dendritic

تفاصيل العنوان

Lack of an Association of PD-1 and Its Ligand Genes with Behcet's Disease in a Chinese Han Population

• Authors : Meng, Qianli; Guo, Haike; Hou, Shengping

• Source: Meng , Q , Guo , H , Hou , S , Jiang , Z , Kijlstra , A & Yang , P 2011 , ' Lack of an Association of PD-1 and Its Ligand Genes with Behcet's Disease in a Chinese Han Population ' , PLOS ONE , vol. 6

تفاصيل العنوان

Membrane particles generated from mesenchymal stromal cells modulate immune responses by selective targeting of pro-inflammatory monocytes

• Authors : Goncalves, Fabiany da C.; Luk, Franka; Korevaar, Sander S.

Subjects: STEM-CELLS; IMMUNOMODULATORY CAPACITY; INTERFERON-GAMMA

• Source: Goncalves , F D C , Luk , F , Korevaar , S S , Bouzid , R , Paz , A H , Lopez-Iglesias , C , Baan , C C , Merino , A & Hoogduijn , M J 2017 , ' Membrane particles generated from mesenchymal stromal

تفاصيل العنوان

Clinical utility of tumor mutational burden in patients with non-small cell lung cancer treated with immunotherapy

• Authors : Hendriks, Lizza E.; Rouleau, Etienne; Besse, Benjamin

Subjects: Immunotherapy; mutation/immunology; non-small cell lung cancer (NSCLC)

• Source: Hendriks , L E , Rouleau , E & Besse , B 2018 , ' Clinical utility of tumor mutational burden in patients with non-small cell lung cancer treated with immunotherapy ' , Translational Lung Cancer

تفاصيل العنوان

Immunotherapy for oncogenic-driven advanced non-small cell lung cancers:Is the time ripe for a change?

• Authors : Remon, J.; Hendriks, L. E.; Cabrera, C.

Subjects: Immunotherapy; EGFR; ALK

• Source: Remon , J , Hendriks , L E , Cabrera , C , Reguart , N & Besse , B 2018 , ' Immunotherapy for oncogenic-driven advanced non-small cell lung cancers : Is the time ripe for a change? ' , Cancer

تفاصيل العنوان

RNA-sequencing in non-small cell lung cancer shows gene downregulation of therapeutic targets in tumor tissue compared to non-malignant lung tissue

• Authors : Reynders, Kobe; Wauters, Els; Moisse, Matthieu

Subjects: Targeted treatment; NSCLC; PD-L1

• Source: Reynders , K , Wauters , E , Moisse , M , Decaluwe , H , De Leyn , P , Peeters , S , Lambrecht , M , Nackaerts , K , Dooms , C , Janssens , W , Vansteenkiste , J , Lambrechts , D & De Ruysscher , D

تفاصيل العنوان

Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC

• Authors : Socinski, M. A.; Jotte, R. M.; Cappuzzo, F.

Subjects: PHASE-III TRIAL; OPEN-LABEL; CANCER

• Source: Socinski , M A , Jotte , R M , Cappuzzo , F , Orlandi , F , Stroyakovskiy , D , Nogami , N , Rodriguez-Abreu , D , Moro-Sibilot , D , Thomas , C A , Barlesi , F , Finley , G , Kelsch , C , Lee , A ,

تفاصيل العنوان

Survival of patients with non-small cell lung cancer having leptomeningeal metastases treated with immune checkpoint inhibitors

• Authors : Hendriks, Lizza E. L.; Bootsma, Gerben; Mourlanette, Jean

Subjects: NSCLC; Immune checkpoint inhibition; Leptomeningeal metastases

• Source: Hendriks , L E L , Bootsma , G , Mourlanette , J , Henon , C , Mezquita , L , Ferrara , R , Audigier-Valette , C , Mazieres , J , Lefebvre , C , Duchemann , B , Cousin , S , le Pechoux , C ,

تفاصيل العنوان

Position of a panel of international lung cancer experts on the approval decision for use of durvalumab in stage III non-small-cell lung cancer (NSCLC) by the Committee for Medicinal Products for Human Use (CHMP)

• Authors : Peters, S.; Dafni, U.; Boyer, M.

Subjects: PROGRAMMED DEATH LIGAND-1; CLINICAL BENEFIT; RADIOTHERAPY

• Source: Peters , S , Dafni , U , Boyer , M , De Ruysscher , D , Faivre-Finn , C , Felip , E , Garrido , P , Girard , N , Guckenberger , M , Haanen , J , Le Pechoux , C , Mornex , F , Ozsahin , M , Paz-Ares ,

تفاصيل العنوان

Current status of immune checkpoint inhibition in early-stage NSCLC

• Authors : Vansteenkiste, J.; Wauters, E.; Reymen, B.

Subjects: immunotherapy; non-small-cell lung cancer; early stage

• Source: Vansteenkiste , J , Wauters , E , Reymen , B , Ackermann , C J , Peters , S & De Ruysscher , D 2019 , ' Current status of immune checkpoint inhibition in early-stage NSCLC ' , Annals of Oncology ,

تفاصيل العنوان